Cardiology Practices
Sell Your Cardiology Practice to a Buyer Who Gets the Model
Cardiology practices carry a different mix of subspecialty care, ancillary services, and reimbursement exposure than most medical practices. We help you get a valuation that reflects that complexity, and find a buyer who will protect care continuity for your patients.
Market Snapshot
A Specialty Buyers Are Actively Chasing
Cardiology practice sales don’t follow the same playbook as other specialties. A few things make this market distinct.
Cardiology Is a Top Consolidation Target
Private equity–backed cardiovascular platforms and health systems are both actively acquiring cardiology groups, creating unusually strong competitive interest in well-run practices.
Ancillary Services Drive Value
Practices with in-office imaging, nuclear stress testing, echocardiography, or a cath lab generate revenue buyers can’t easily replicate — and price that capability accordingly.
Reimbursement Risk Shapes Buyer Behavior
Ongoing Medicare payment pressure and site-neutral policy proposals make buyers pay close attention to how much of your revenue depends on site-of-service differentials.
Valuation
Three Things That Move Cardiology Practice Value
Ancillary & Imaging Revenue
Owned imaging, vascular labs, and cath lab capacity add durable revenue streams that command a premium over E&M-only practices.
Subspecialty Mix
Interventional, electrophysiology, and structural heart capabilities are valued differently than general or non-invasive cardiology alone.
Payer Mix & Reimbursement Exposure
A healthy commercial payer mix, combined with limited exposure to site-neutral payment risk, gives buyers a clearer picture of future revenue.
Buyer Landscape
Understanding Your Buyer Pool
Because referral relationships and inpatient coverage carry real weight in cardiology, we help you understand not just what each buyer will pay, but how they tend to run a practice — and support its physicians — after close.
| Buyer Type | What They're Looking For |
|---|---|
| Private equity–backed cardiovascular platforms | Multi-site groups with strong ancillary revenue, subspecialist depth, and room to standardize operations across sites. |
| Hospitals & health systems | Practices that strengthen referral networks, inpatient coverage, and service-line growth within their existing footprint. |
| Individual practitioners & small groups | Solo or small practices, often prioritizing patient continuity and clinical culture as much as price. |
Our Process
How We Approach a Cardiology Practice Sale
01
Confidential Consultation
Understanding your subspecialty mix, ancillary services, and what continuity means to you.
02
Specialty Valuation
Accounting for ancillary and imaging revenue, payer mix, and subspecialty mix.
03
Confidential Marketing
Preparing a confidential executive summary and readying your practice for the market.
04
Buyer Vetting & Offers
Introducing vetted buyers and evaluating how each plans to support your physicians and ancillary services.
05
Negotiation & Diligence
Navigating diligence, including Stark/anti-kickback compliance, cath lab and imaging accreditation, and payer contracts.
06
The Handoff
A transition plan built to keep patients, physicians, and referral sources intact.
Proof
Our Track Record
85%
of engagements reach close
80+
combined years of healthcare-specific brokerage experience
95%
of clients land within 10% of expected valuation
FAQ
Common Questions
Will my cardiologists stay on after a sale?
In most transitions, yes — buyers acquiring a cardiology practice are typically buying the physician group along with its referral relationships and ancillary infrastructure, since continuity of care and inpatient coverage are central to the deal's value. We prioritize buyers who plan to retain your physicians, and we build retention terms into the deal structure wherever possible, not just the transition plan.
How do ancillary services like imaging and cath labs affect my valuation?
Ancillary revenue — nuclear stress testing, echocardiography, vascular ultrasound, and cath lab ownership — is often valued at a premium over standard E&M revenue, since it's harder for a buyer to replicate and represents a more durable income stream. We help you document and present this revenue clearly so buyers price it as the asset it is, rather than folding it into general practice revenue.
How does site-neutral payment policy affect what my practice is worth?
Buyers are increasingly cautious about revenue that depends heavily on site-of-service payment differentials, since ongoing site-neutral proposals could narrow that gap over time. We help position your practice's value around its clinical strengths, payer mix, and subspecialty depth — not just its current reimbursement environment — so the valuation holds up under buyer scrutiny.